We are live on
!
Find out more
SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
1-Year Est. Return
41.48%
This Fund
S&P 500
This Quarter
Est. Return
+2.86%
1 Year Est. Return
+41.48%
3 Year Est. Return
+28.44%
5 Year Est. Return
+53.22%
10 Year Est. Return
–
AUM
$8.31B
AUM Growth
+$271M
(+3.4%)
Cap. Flow
+$42.6M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
291
New
12
Increased
68
Reduced
154
Closed
16
Top Buys
| 1 |
DuPont de Nemours
DD
|
+$142M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$62.5M |
| 3 |
Pfizer
PFE
|
+$26.7M |
| 4 |
Eaton
ETN
|
+$23.2M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$15.3M |
Top Sells
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$141M |
| 2 |
Boeing
BA
|
+$74.3M |
| 3 |
JPMorgan Chase
JPM
|
+$25.5M |
| 4 |
UN
Unilever NV New York Registry Shares
UN
|
+$15.9M |
| 5 |
Manulife Financial
MFC
|
+$11.6M |
Sector Composition
| 1 | Financials | 15.28% |
| 2 | Healthcare | 13.04% |
| 3 | Industrials | 9.52% |
| 4 | Energy | 8.89% |
| 5 | Technology | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novartis
NVS
$291B
| $227M | 2.73% |
2,950,672
-152,484
| -5% | -$11.5M |
|
|
UN
2
DELISTED
Unilever NV New York Registry Shares
UN
| $217M | 2.61% |
3,676,705
-272,747
| -7% | -$15.9M |
|
|
RDS.B
3
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $195M | 2.34% |
3,110,782
-118,848
| -4% | -$6.82M |
|
4
HSBC
HSBC
$345B
| $190M | 2.29% |
4,210,477
-129,102
| -3% | -$5.71M |
|
5
BCE
BCE
$20.6B
| $172M | 2.08% |
3,683,295
-76,760
| -2% | -$3.59M |
|
6
Diageo
DEO
$47.5B
| $163M | 1.96% |
1,229,860
-5,948
| -0.5% | -$769K |
|
|
SI
7
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $162M | 1.95% |
2,293,420
+882,806
| +63% | +$62.5M |
|
8
Johnson & Johnson
JNJ
$602B
| $162M | 1.95% |
1,247,650
-26,002
| -2% | -$3.45M |
|
9
Cisco
CSCO
$432B
| $160M | 1.92% |
4,745,965
-167,148
| -3% | -$5.32M |
|
10
Microsoft
MSFT
$2.98T
| $158M | 1.91% |
2,126,952
-72,382
| -3% | -$5.29M |
|
11
Chevron
CVX
$366B
| $157M | 1.89% |
1,332,768
-35,231
| -3% | -$3.85M |
|
12
Chubb
CB
$133B
| $154M | 1.86% |
1,083,552
-26,686
| -2% | -$3.86M |
|
|
13
JPMorgan Chase
JPM
$912B
| $152M | 1.84% |
1,596,320
-276,160
| -15% | -$25.5M |
|
|
14
Pfizer
PFE
$143B
| $152M | 1.82% |
4,473,901
+832,093
| +23% | +$26.7M |
|
15
AstraZeneca
AZN
$263B
| $150M | 1.81% |
2,215,074
+108,942
| +5% | +$6.88M |
|
|
16
DuPont de Nemours
DD
$18.1B
| $149M | 1.79% |
+849,950
| New | +$142M |
|
17
Welltower
WELL
$170B
| $147M | 1.76% |
2,085,814
-9,729
| -0.5% | -$707K |
|
18
Merck
MRK
$315B
| $144M | 1.73% |
2,354,829
+68,463
| +3% | +$4.15M |
|
19
AT&T
T
$153B
| $141M | 1.69% |
4,755,345
-134,969
| -3% | -$3.83M |
|
20
MetLife
MET
$60.3B
| $135M | 1.63% |
2,600,107
+117,793
| +5% | +$5.74M |
|
21
Wells Fargo
WFC
$267B
| $135M | 1.63% |
2,448,571
-31,970
| -1% | -$1.7M |
|
22
NextEra Energy
NEE
$186B
| $133M | 1.6% |
3,617,552
-118,532
| -3% | -$4.34M |
|
23
Travelers Companies
TRV
$71.8B
| $124M | 1.5% |
1,014,861
-13,743
| -1% | -$1.72M |
|
24
Altria Group
MO
$122B
| $123M | 1.48% |
1,937,484
-92,707
| -5% | -$6.18M |
|
|
RTN
25
DELISTED
Raytheon Company
RTN
| $121M | 1.46% |
649,412
-24,690
| -4% | -$4.35M |
|
Similar funds
CNC
SRAM
PA
FBP
SGMP
RG
LFA
RHFI